Imerys S.A.
IMYSF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.11 | -0.56 | -0.10 | 0.00 |
| FCF Yield | 0.00% | 0.00% | 0.00% | 0.00% |
| EV / EBITDA | 28.97 | 24.17 | 36.94 | 17.72 |
| Quality | ||||
| ROIC | 0.99% | 0.00% | 4.91% | 0.00% |
| Gross Margin | 30.25% | 100.00% | 28.28% | 100.00% |
| Cash Conversion Ratio | – | – | – | – |
| Growth | ||||
| Revenue 3-Year CAGR | -5.82% | -14.60% | -8.47% | -0.10% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | -100.00% |
| Safety | ||||
| Net Debt / EBITDA | 10.95 | 0.00 | 13.02 | 0.00 |
| Interest Coverage | 6.01 | 3.73 | 0.00 | 6.42 |
| Efficiency | ||||
| Inventory Turnover | 0.88 | 0.00 | 0.82 | 0.00 |
| Cash Conversion Cycle | 100.75 | 0.00 | 109.35 | 0.00 |